EW price target
Edwards Lifesciences Corporation · end-of-day data as of Oct 16, 2026
Edwards Lifesciences Corporation
$86.60+4.8%
Buy · 30 analystsPT $99.77 +15.2%
The average price target of the 18 analyst firms that published one in the last 12 months is $99.77 for EW, 15.2% above the last close of $86.60 on Oct 16, 2026. Targets range from $89.27 to $110.85, with a median of $99.08. Rating consensus: Buy.
Summary
- Target upside+15.2%
- ConsensusBuy
Analyst price targets
Low$89.27
Average$99.77
Median$99.08
High$110.85
Upside+15.2%
18 firms with a target in the last 12 months · last close $86.60 · as of Oct 16, 2026
Wells Fargo$1002025-12-18
Canaccord Genuity$872025-12-17
Robert W. Baird$892025-12-16
Barclays$1012025-12-08
Canaccord Genuity$892025-12-05
RBC Capital$992025-12-05
+18 more
Goldman Sachs$982026-02-11
Piper Sandler$1032026-02-11
Truist Financial$922026-02-11
UBS$922026-02-04
Piper Sandler$972026-01-20
Stifel Nicolaus$1092026-01-20
+6 more
Barclays$1092026-04-27
BTIG$1062026-04-24
Canaccord Genuity$902026-04-24
Evercore ISI$942026-04-24
Truist Financial$912026-04-24
Mizuho Securities$962026-04-13
UBS$1112026-07-28
Leerink Partners$1002026-07-24
Piper Sandler$1002026-07-24
Truist Financial$962026-07-16
RBC Capital$1102026-07-13
Evercore ISI$1022026-07-06
+1 more
— actual price● bullish target● bearish targethover a dot to see the analysts behind it · wheel or drag to move through time · drag the price axis on the right to stretch it · double-click resets
Strong buy 5 · Buy 18 · Hold 7 · Sell 0 · Strong sell 0